Rising CMS Pressures And Margin Risks Will Drag Performance
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 10 Analysts
Published
07 Aug 25
Updated
07 Aug 25
AnalystLowTarget's Fair Value
US$13.28
10.2% overvalued intrinsic discount07 Aug
US$14.64
1Y
72.4%7D
9.2%